View Agent
| Agent Info | |
| Agent: | alisertib |
| Synonyms: | MLN8237 |
| Drug Status For Certain Diseases: | phase II |
| Classification: | an investigational, oral, selective inhibitor of aurora kinase A |
| Target: | aurora kinase A |
| KEGG Pathway: | Oocyte meiosis |
| Wiki Pathway: | APC/C-mediated degradation of cell cycle proteins Gastric Cancer Network 1 EGF/EGFR Signaling Pathway JAK/STAT Integrated Breast Cancer Pathway |